Search results
Leonard Schleifer
Fortune· 2 hours agoRegeneron is a research-oriented biotech, founded by Schleifer, that had no product on the market for its first 20 years. Today its monoclonal antibodies ...
Biohaven doses first subject in Phase I/II tumour treatment study
Clinical Trials Arena via Yahoo Finance· 5 days agoFurthermore, Biohaven signed a clinical supply agreement with Regeneron Pharmaceuticals. Under this...
FibroGen To Begin Trials on Tumor Treatment After FDA OK
Morningstar· 18 hours agoFood and Drug Administration had granted its Investigational New Drug for FG-3165, a monoclonal antibody treatment. The company can advance to a Phase 1 ...
FibroGen Stock Is Surging After The Bell: What's Going On? - FibroGen (NASDAQ:FGEN)
Benzinga· 17 hours agoThe company also announced a new clinical trial supply agreement with Regeneron. What Happened:...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food and Drug Administration (FDA) has extended by three months the target action date of ...
Quadruplet Regimens Have Become Standard for Multiple Myeloma
MedPage Today· 4 days agoWhile triplet regimens were once standard for newly diagnosed multiple myeloma, more recent studies...
Intralesional Therapy for Melanoma Effective, May Have Systemic Activity
MedPage Today· 2 days agoPreoperative antibody fusion daromun significantly reduced relapse versus upfront surgery
Cell therapy reckoning: How a 'remarkable resolution of lupus' carried CAR-T from cancer to...
FierceBiotech· 5 days agoThis story is part 3 in a four-part series about cell therapy created by the Fierce Biotech team....
Triglycerides Down With ANGPTL3 RNA Interference Agent
MedPage Today· 6 days agoAn RNA interference therapy, targeting ANGPTL3 in the liver, drastically reduced fasting triglycerides in people with mixed hyperlipidemia, the ARCHES-2 trial showed. Used atop usual statins ...
